Maynard Um
-
-
-
-
-
-
-
SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) to be Added to Russell 3000® and Russell 2000 Indexes
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Announces Positive Data from Phase 2a Trial of SLS009 plus Zanubrutinib
-
-
-
-
-
-
-
SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
SELLAS Life Sciences (SLS) Granted FDA Rare Pediatric Disease Designation for SLS009
-
-
423,216 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

